A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

Clinical trial NCT00118638 · COMPLETED

Trial details

NCT number: NCT00118638
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia Non-Myeloid Malignancies

Start date: 2004-03-01
Primary completion: 2004-12-01
Enrollment: 705

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.